Physician Assistant Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Lynette Weitman Nicholson

Physician Assistant, Medical Pembroke Pines, FL Physician Assistant

NPI 1538378823 CMS profile 10735536

160 S Flamingo Rd, Pembroke Pines, FL 33027

Open in the dashboard

General payments

$48,996

814 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Lynette Weitman Nicholson of Pembroke Pines, FL is reported in the CMS Open Payments database as having received $48,996 across 814 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Physician Assistant, Medical profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $18,768 246
2024 General $4,147 185
2023 General $12,381 142
2022 General $6,612 101
2021 General $7,087 140

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Lynette Weitman Nicholson
  • Physician Assistant, Medical median
  • Middle half of Physician Assistant, Medical
  • National median

In program year 2025, general payments to Lynette Weitman Nicholson were reported at $18,768. Among 16,675 Physician Assistant, Medical profiles paid that year, the median was $214 and the middle half received between $62 and $755.

Show as a table
Year Lynette Weitman Nicholson Physician Assistant, Medical median Middle half National median
2019 $0 $61 $19–$193 $163
2020 $0 $20 $14–$64 $114
2021 $7,087 $156 $41–$563 $132
2022 $6,612 $185 $55–$649 $149
2023 $12,381 $199 $58–$717 $160
2024 $4,147 $206 $62–$740 $164
2025 $18,768 $214 $62–$755 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Lilly USA, LLC $20,343 69 payments
  2. UCB, Inc. $14,102 116 payments
  3. Janssen Biotech, Inc. $2,609 41 payments
  4. Amgen Inc. $2,438 142 payments
  5. AbbVie, Inc. $2,356 110 payments
  6. Mallinckrodt Hospital Products Inc. $1,453 60 payments
  7. Novartis Pharmaceuticals Corporation $943 54 payments
  8. Aurinia Pharma U.S., Inc. $681 25 payments
  9. AstraZeneca Pharmaceuticals LP $667 31 payments
  10. E.R. Squibb & Sons, L.L.C. $418 26 payments
  11. Other $2,985 140 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $25,215 33 payments
  2. Food and Beverage $15,607 765 payments
  3. Consulting Fee $7,020 4 payments
  4. Travel and Lodging $1,047 9 payments
  5. Education $75 2 payments
  6. Gift $32 1 payment
Products named General payments · program years 2021–2025
  1. TALTZ $20,343 69 payments
  2. Bimzelx $13,088 59 payments
  3. TREMFYA $2,537 37 payments
  4. ACTHAR $1,453 60 payments
  5. RINVOQ $1,407 66 payments
  6. Cimzia $1,014 57 payments
  7. Otezla $779 47 payments
  8. LUPKYNIS $681 25 payments
  9. Enbrel $655 39 payments
  10. SAPHNELO $641 30 payments
  11. Other $7,584 407 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 24 drugs

Part D claims

1,266

Median for Physician Assistant: 241

Drug cost

$649,320

Median for Physician Assistant: $4,110

Branded share of claims

28.4%

Median for Physician Assistant: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Enbrel Sureclick Etanercept Brand 25 $218,789
Cimzia (2 Pack) Certolizumab Pegol Brand 22 $140,966
Cosentyx Sensoready (2 Pens) Secukinumab Brand 15 $123,933
Benlysta Belimumab Brand 14 $67,795
Tymlos Abaloparatide Brand 16 $41,762
Prolia Denosumab Brand 18 $31,085
Hydroxychloroquine Sulfate Generic 186 $7,540
Methotrexate Methotrexate Sodium Brand 236 $5,417
Mycophenolate Mofetil Generic 22 $3,183
Prednisone Generic 273 $3,132

The 10 drugs with the highest cost, of 24 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 114,276 Part D prescribers listed as Physician Assistant; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 13 billing codes

Paid by Medicare

$10,314

Medicare's payments for the services billed

Medicare patients

64

Average age 73

Services billed

784

53 women, 11 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 75%
High blood pressure 63%
Osteoporosis 50%
Diabetes 36%
Chronic kidney disease 31%
Depression 27%
Ischemic heart disease 25%
COPD 22%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

First 5 of 31 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
ACTHAR
$507 — —
Cimzia
$342 22 —
TREMFYA
$324 — —
SKYRIZI
$311 — —
LUPKYNIS
$290 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

See more in the dashboard: 25 with a free account, all 31 with Patron

Records

814 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant, Medical in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record